CD8A and neoplasm: Furthermore, although the percentage of total T cells (% CD3+CD56− cells of total PBMCs) was not altered in non-adjuvant-treated patients after resection of the primary tumor (Fig. 1e), the percentage of CD8+ T cells (% of total T cells) was significantly increased (P* = 0.034, Fig. 1f).